Clinical Trial Update: A Study to Evaluate Sigma-1 and Dopamine-2 Receptor Occupancy by Pridopidine in the Human Brain of Healthy Volunteers and in Patients With Huntington's Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating sigma-1 and D2 receptor occupancy by pridopidine in healthy volunteers and Huntington's disease patients; completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• Pridopidine (pridopidine)

Snippet

Sponsor: Prilenia | Conditions: Health Volunteers, Huntington Disease | Phase 1 | Status: COMPLETED | Results posted: 2021-11-16